Assoc. Prof. Dr. Özlem Şahin Balçık

Анемия

Талассемия

Лейкоз

Лимфома

Миелома

Хронические миелопролиферативные заболевания

Хронический миелоидный лейкоз

Нарушения свертывания

Медицинский факультет Университета Анкары

Больница Ankara Numune, внутренние болезни

Больница Ankara Numune, гематология

2003–2007 — Учебно-исследовательская больница Анкара Нумуне — Гематология

2007–2009 — Онкологическая учебно-исследовательская больница имени доктора Абдуррахмана Юртарслана, Анкара — Гематология

2010–2011 — Отделение трансплантации костного мозга больницы Bayındır, Анкара

2011–2016 — Университет Тургут Озал — Гематология

2017–настоящее время — Больница Medical Park Samsun

Турецкое общество специалистов по внутренним болезням

Турецкое гематологическое общество

Ассоциация специалистов-гематологов

Международное гематологическое общество

Европейская гематологическая ассоциация

A1. Balçik, O.S., Oztürk, M., Dağli M., Kaftan, O., Koşar, A., Karaaslan, Y., Kirazli, S., "Increased erythropoietin levels in reactive thrombocytosis,” Haematologia (Budap)., 32(1), 59-65 (2002).

A2. Kaftan, O., Balcik, O.S., Cipil, H., Ozet, G., Bavbek, N., Koşar, A., Dagdas, S., "Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis,” Clin Appl Thromb Hemost., 11(4), 449-54 (2005).

A3. Balçık, O.Ş., Dağdaş, S., Güler S.K., Özet, G., Oymak, A., Çelik, Z., Zengin, N., Öksüzoğlu, B., Aylı, M., Dinçer, S., Albayrak, M., “Otolog periferik kök hücre toplama rejimlerinin CD34(+) hücre sayısı üzerine etkisi: Tek merkez deneyimi," Turkiye Klinikleri J Med Sci., 28, 640-7 (2008).

A4. Yokus, O., Albayrak, M., Balcik, O.S., Ceran, F., Dagdas. S., Yilmaz, M., Ozet, G., "Risk factors for thrombophilia in young adults presenting with thrombosis,” Int J Hematol., 90(5), 583-90 (2009).

A5. Aydin, Y., Berker, D., Ustün, I., Balcik, O., Balli, D.N., Delibasi, T., Peksoy, I., Guler, S., "A very rare cause of aplastic anemia: Graves disease,” South Med J., 101(6), 666-7 (2008).

A6. Balçık, Ö.Ş., Dağdaş, S., Albayrak, M., Efe, C., Yokuş, O., Ceran, F., Özet, G., Yılmaz, M., Albayrak, L., "Kronik lenfositik lösemi seyrinde multipl miyelom gelişimi: Olgu sunumu,” International Journal of Hematology and Oncology., 18(4), 238-41 (2008).

A7. Balçık, Ö.Ş., Albayrak, M., Dağdaş, S., Ceran, F., Özet, G., Demirağ F, Yokuş, O., "A rare extramedullary involvement in myeloma: Lung parenchyma and association with unfavorable chromosomal abnormalities,” Turk J Hematol., 27(2), 109-12 (2010).

A8. Yokuş, O., Balçık ö.Ş., Albayrak, M., Ceran, F., Dağdaş, S., Yılmaz, M., Özet, G., "Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis," Turk J Hematol., 27(3), 162-7 (2010).

A9. Albayrak, M., Balçık, Ö,Ş., Dağdaş, S., Yılmaz, M., Ceran, F., Yokuş, O., Özet, G., "Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression,” Turk J Hematol., 27(3), 182-9 (2010).

A10. Yokus, O., Albayrak, M., Balcik, O.S., Gokalp, S.S., Ersaydı, M., Akar, M., Tekin,Y., Bozkurt, H.K., "A rare co-incidental presentation: Multiple myeloma and pleural adenocarcinoma – A case report,” International Journal of Hematology and Oncology., 21(2), 106-10 (2011).

A11. Kargılı, A., Çipil, H.Ş., Karakurt, F., Kasapoğlu, B., Koca, C., Aydın, M., Uysal, S., İkizek, M., Uz, E., Balçık, O.Ş., Kosar, A., “Hemostatic alterations in fatty liver disease,” Blood Coagul Fibrinolysis., 21(4), 325-7 (2010).

A12. Yokus, O., Balcik, O.S., Albayrak, M., “Patient with megaloblastic anemia, admitted with pancytopenia and walking difficulty, although vitamin B12 and MCV levels were normal,” Pak J Med Sci., 26(3), 736-9 (2010).

A13. Uz, E., Alıcı, Ö., Balçık, Ö.Ş., Kanbay, M., Işık, A., Uz, B., Kaya, A., Koşar, A., “Portal vein thrombosis secondary to Klebsiella oxytoca bacteriemia,” Turk J Hematol., 27(3), 213-5 (2010). SCI-Expanded tarafından taranmaktadır)

A14. Kosar, A., Kasapoglu, B., Kalyoncu, S., Turan, H., Balcik, O.S., Gümüs, E.I., “Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study,” Blood Coagul Fibrinolysis., 22(1), 14-8,(2011).

A15. Albayrak, M., Balcik, O.S., Alan, S., Dincer, S.L., Yuksel, M.K., Albayrak, A., “A rare cause of fever, hepatosplenomegaly, and thrombocytopenia: Hepatosplenic gamma/delta T-cell lymphoma,” Pathol Oncol Res., 17, 421-3, (2011).

A16. Balcik, O.S., Albayrak, M., Uyar, M.E., Dagdas, S., Yokus, O., Ceran, F., Cipil, H., Kosar, A., Ozet, G., “Serum TAFI Levels in Patients with Newly Diagnosed Multiple Myeloma,” Blood Coagul Fibrinolysis., 22(4), 260–3 (2011).

A.17. Albayrak, M., Aksu, S., Celebi, H., Albayrak, A., Ginis, Z., Yagcı, S., Balcık, O.S., Yokus, O., Haznedaroglu, I.C., “ Striking Promotion of the in vitro Myeloma Monoclonal Immunoglobulin Aggregation by Ankaferd Hemostat,” I nternational J ournal of H ematology and O ncology., 22(1), 15-22 (2012).

A18. Balcik, O.S., Akdeniz, D., Cipil, H., Uysal, S., Isik, A., Kosar, A. "Heparin Platelet Factor 4 Antibody Positivity In Pseudothrombocytopenia," Clinical and Applied Thrombosis/Hemostasis., 18(1), 92-5 (2012).

A19. Balcık, O.S., Albayrak, M., Dagdas, S., Helvacı, N., Yokus, O., Ceran, F., Ozet, G., Ergöçen, S., “Conventional cytogenetics and FISH [ del13q, del17p, t(11;14), t(4;14)] findings and their relationship with other risk factors in multiple myeloma,” International Journal of Hematology and Oncology., 21(4), 203-9 (2011).

A20. Yokus, O., Uckurt, Y., Demir, A.S., Kalyon, S., Balcik, O.S., Akdeniz, D., “Antiphospholipid syndrome with hemophilia B: A case report represented by recurrent thrombosis/ bleeding attacks,” Pak J Med Sci. 27(4), 922–5 (2011).

A21. Balcik, O.S., Akdeniz, D., Cipil, H., Ikizek, M., Uysal, S., Kosar, A., Yigitoglu, R., “Thrombopoietin Levels in Patients with Non-Alcoholic Fatty Liver Disease” Saudi Medical Journal. 33(1), 30-3 (2011).

A22. Albayrak, M., Celebi, H., Albayrak, A., Sayilir, A., Yesil, Y., Balcik, O.S., Yokus, O., Celik, T., "Elevated Serum Angiotensin Converting Enzyme Levels as a Reflection of Bone Marrow Renin-Angiotensin System Activation in Multiple Myeloma" Journal of the Renin-Angiotensin-Aldosterone System. 13(2), 259-64 (2012). Epub 2012 Feb 16.

A23. Isik, A., Balcik, O.S., Akdeniz, D., Cipil, H., Uysal, S., Kosar, A., “Relationship between Some Clinical Situations, Autoantibodies, and Pseudothrombocytopenia,” Clinical and Applied Thrombosis/Hemostasis. 18(6), 645-9 (2012). Epub 2012 Mar 5.

A24. Balcık OS., Koroglu, M., Cipil, H., Kaftan, O., Maral, S., Gurel, A., Goker, H., Haznedaroglu, IC., Kosar, A., “A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase-I Clinical Study Indicating the Safety of Topical Ankaferd Hemostat in Healthy Volunteers,” I nternational J ournal of H ematology and O ncology., 22(4) 267-74 (2012).

A25. Balcik, O.S., Bilen, S., Ulusoy, E.K., Akdeniz, D., Uysal, S., Ikizek, M., Ak, F., Kosar, A., “Thrombopoetin and Mean Platelet Volume in Patients with Ischemic Stroke” Clinical And Applied Thrombosis/Hemostasis. 19(1) 92-5 (2013).

A26. Karataş, S.G., Bayrak, R., Balcik, O.S., Yalcin, K.S., Atici, E., Akyildiz, U., Kosar, A., “Human Immunodeficiency Virus (HIV) Negative Human Herpes Virus-8 (HHV- 8) Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature,” Turk J Hematol., 30, 67-71 (2013).

A27. Balcik, O.S., Aksoy, C., Akdeniz, D., Akkaya, C., Guvenc, B., Dinçer, S., “ The comparison of standard and salvage chemotherapy regimens regarding to CD34(+) peripheric stem cell harvesting success,” International Journal of Hematology and Oncology., 23(3) 184-192 (2013).

A28. Ceylan, H., Kocabey, S., Unal Gulsuner, H., Balcik, O.S., Guler, M., Tekinay, A., "Bone-like apatite nucleating nanofibers induce differentiation of human mesenchymal stem cells into mature osteoblasts,” Biomacromolecules., 15(7) 2407-18 (2014).

A29. Maral S, Acar M, Balcik OS, Uctepe E, Hatipoglu OF, Akdeniz D, Altun HU, Kosar A, Gunduz M, Gunduz E. “Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study.” Medicine (Baltimore). 2015 Apr; 94(16):e732. doi: 10.1097/MD.0000000000000732.

D1. Balçık, Ö.Ş., "JNC-6 raporuna göre hipertansiyonun tanı ve tedavisi, " İlaç ve Tedavi Dergisi. , 12(1), 47-8 (1999).

D2. Balçık, Ö.Ş., "Trandolapril diyabetik nöropatiyi geriletiyor," İlaç ve Tedavi Dergisi., 12(2), 122 (1999).

D3. Balçık, Ö.Ş., Karaaslan, Y., "Romatoid artritte kombine DMARD kullanımı," İç Hastalıkları Progres., 1(4), 125-9 (2000).

D4. Balçık, Ö.Ş., Kaftan, O., "Hiperkolesterolemi ve gode bırakmayan ödem," Yeni Tıp Dergisi., 17(3), 164 (2000).

D5. Öztürk, M., Balçık, Ö.Ş., "Olgu tartışması," İç Hastalıkları Progres., 2(4), 134 (2001).

D6. Balçık, Ö.Ş., "Akut sinüzitli erişkinlerde antibiyotiklerin uygun kullanımı," İç Hastalıkları Progres., 2(5), 157-8 (2001).

D7. Balçık, Ö.Ş., Koçkar, C., Sipahi, N., "Halsizlik, kilo kaybı, çok su içme, çok idrara çıkma," Yeni Tıp Dergisi., 18(4), 217-8 (2001).

D8. Balçık, Ö.Ş., "Uzun etkili B2 agonistler: Formoterol ve salmeterolden hangisi daha iyi?," İç Hastalıkları Progres., 2(7), 221-2 (2001).

D9. Balçık, Ö.Ş., "Derin ven trombozu," İç Hastalıkları Progres. , 2(7), 229-30 (2001).

D10. Balçık, Ö.Ş., "Aşılamanın romatolojik bulguları," İç Hastalıkları Progres., 2(8), 260 (2001).

D11. Balçık, Ö.Ş., "Romatolojik hastalıklarda ımmunizasyon," İç Hastalıkları Progres., 2(8), 261 (2001).

D12. Balçık, Ö.Ş., Karakuş, S., "Primer trombositemi," İç Hastalıkları Progres., 2(12), 372-6 (2001).

D13. Balçık, Ö.Ş., "İrritabl barsak sendromu, " İç Hastalıkları Progres., 3(5), 149-51 (2002).

D14. Balçık, Ö.Ş.,"Yeni kolesterol tedavi rehberi (NCEP-ATP III) ışığında günümüzde hiperlipidemi tedavisi," İç Hastalıkları Progres., 4(1), 12-21 (2003).

D15. Balçık, Ö.Ş., Kaftan, O., "Antibiyotiğe bağlı kolitler," İç Hastalıkları Progres., 4(4), 178-80 (2003).

D16. Dagdas, S., Albayrak, M., Balcik, O.S., Ozet, G., Ceran, F., Erekul, S., "A case of multicentric HHV-8 positive Castleman’s disease presenting with marked lymphocytosis," Turkish Journal of Cancer., 39(3), 110-4 (2009).

D17. Balçık, Ö.Ş., Helvacı, N., Albayrak, M., Yokuş, O., Ceran, F., Dağdaş, S., Özet, G., "Myelodysplastic syndrome with complex cytogenetic abnormalities and immunocompromised in two siblings," Acta Oncologica Turcica., 43, 88-90 (2010).

D18. Yokuş, O., Balcık, Ö.Ş., Albayrak, M., “The efficiency and side-effects of low-dose fludarabine-cyclophosphamide in the treatment of chronic lymphocytic leukemia,” J Clin Exp Invest., 1(1), 63-5 (2010).

D19. Yokuş, O., Balcık, Ö.Ş., Albayrak, M., “Diagnosis and treatment strategies of thrombophilic risk factors,” J Clin Exp Invest., 1(2), 125-33 (2010).

D20. Yokuş, O., Kurnaz, F., Balçık, Ö.Ş., Uz, B., Albayrak, M., “Coexistance of JAK2V617F mutation and BCR/ABL translocation in one patient,” J Clin Exp Invest., 1(2), 138-40 (2010).

D21. Turgut, F., Çarlıoğlu, A., Alkan, R., Akdeniz, D., Haltaş, H., Balçık, Ö.Ş., Uz, E., Karataş, Ö.F., “Erdosteinin diyabetik ratlarda böbrek hasarı üzerine koruyucu etkisi,” Türk Nefroloji Diyaliz ve Transplantasyon Dergisi., 19(3), 157-61 (2010).

D22. Helvacı, M.R., Albayrak, M., Balçık, Ö.Ş., Çelebi, H., Ertekin, F., “Hematocrit value and body mass index,”. Endokrinolojide Yönelişler., 19(5), 131-3 (2010).

D23. Albayrak, M., Balcik, O.S., Aki, S.Z., Gokmen, A., Ceran, F., Yokus, O., Dagdas, S., Ayli, M., Ozet, G., “Evaluation of 143 cases with immune thrombocytopenic purpura in the view of clinical course and response to treatment,” The Eurasian Journal of Medicine., 42, 120-3 (2010).

D24. Yokuş, O., Balçık, Ö.Ş., Albayrak, M., Ceran, F., Yılmaz, M., Dağdaş, S., Özet, G., “Thrombophilic Risk Factors in Women with Recurrent Abortion,” J Clin Exp Invest., 1(3), 168-72 (2010).

D25. Alkan, R., U, E., Balçık, Ö.Ş., Uz, B., Bayram, Y., “Is end-stage renal disease always symptomatic?,” J Clin Exp Invest., 1(3), 216-18 (2010).

D26. Balçık, Ö.Ş., Gümüş, İ.İ., Kamalak, Z., Çipil, H., Kaygusuz, İ.Ç., Kosar, A., “Safety of imatinib during pregnancy: Report of two cases and review of literature,” Turkiye Klinikleri J Gynecol Obst., 20(6), 387-91 (2010).

D27. Balcık, O.S., Albayrak, M., Dinçer, S.L., Yüksel, M., Pak, I., Çiçek, C., Oymak, A., Çelik, Z., “A Rare Involvement Region In Primary Cutaneous B Cell Lymphoma: Scalp, ” Ortadoğu Medical Journal., 2(4), 42-5 (2010).

D28. Yokuş, O., Yılmaz, B., Albayrak, M., Balçık, Ö.Ş., Helvacı, M.R., Sennaroğlu, E., "The Significance of Serum Transferrin Receptor in Diagnosis of the Coexistence of Anemia of Chronic Disease and Iron Deficiency Anemia," The Eurasian Journal of Medicine, 43, 9-12 (2011).

D29. Yokuş, O., Gökalp, S.S., Balçık, Ö.Ş., Albayrak, M., Ersaydı, M., “Homozigot JAK2 Mutasyonlu Erkek Hastada Karotis Stenozu ve Esansiyel Trombositemi Birlikteliği: Olgu Sunumu,” Fırat Tıp Dergisi., 16(1), 38-40 (2011).

D30. Balçık, Ö.Ş., Akkaya, Ç., Uz, B., Aksoy, C., Güvenç, B., Dinçer, S., “The efficacy and safety of hypertonic citrate as catheter-locking solution in hematopoietic stem cell transplant recipients,” Türkiye Klinikleri Cardiovascular Sciences., 23(1), 48-53 (2011).

D31. Yılmaz, B., Tunca, H., Balçık, Ö.Ş., Hasa, S.A., Sennaoğlu, E., “Metabolik Sendromlu Kadın Hastalar Ve P Dalga Dispersiyonu,” Ortadoğu Medical Journal., 3(1), 27-31 (2011).

D32. Balcik, Ö.S., Albayrak, M., Dağdaş, S., Tamözlü, T., Yokuş, O., Ceran, F., Özet, G., “Familial Myeloproliferative Diseases and JAK2 Mutation: Two Case Reports and Review of Literature,” Ortadoğu Medical Journal., 3(1), 41-4 (2011).

Kaya T, Dilek A, Ozaras R, Balcik OS, Leblebicioglu H. COVID 19 and febrile neutropenia: Case report and systematic review. Travel Med Infect Dis. 2022;47:102305. doi:10.1016/j.tmaid.2022.102305. PMID: 35272019.